Literature DB >> 12606648

alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats.

Liping Gao1, Chongxue Zhu, Edwin K Jackson.   

Abstract

Hypertension in spontaneously hypertensive rats (SHRs) is due in part to enhanced effects of vasoactive peptides on the renal vasculature. We hypothesize that the G(i) signal transduction pathway enhances renovascular responses to vasoactive peptides in SHRs more so than in normotensive Wistar-Kyoto (WKY) rats. To test this hypothesis, we examined in isolated perfused kidneys from SHRs and WKY rats the renovascular responses (assessed as changes in renal perfusion pressure in mm Hg) to angiotensin II (10 nM) and vasopressin (3 nM) in the presence and absence of UK-14,304 [5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine; an agonist that selectively activates the G(i) pathway by stimulating alpha(2)-adrenoceptors]. In SHR, but not WKY, kidneys, UK-14,304 (10 nM) enhanced (P < 0.05) renovascular responses to angiotensin II (control WKY, 43 +/- 6; UK-14,304-treated WKY, 52 +/- 19; control SHR, 66 +/- 17; UK-14,304-treated SHR, 125 +/- 16) and vasopressin (control WKY, 42 +/- 17; UK-14,304-treated WKY, 36 +/- 11; control SHR, 16 +/- 8; UK-14,304-treated SHR, 83 +/- 17). Pretreatment of SHRs with pertussis toxin (30 microg/kg, intravenously, 3-4 days before study) to inactivate G(i) blocked the effects of UK-14,304. Western blot analysis of receptor expression in whole kidney and preglomerular microvessels revealed similar levels of expression of AT(1), V(1a), and alpha(2A) receptors in SHRs compared with WKY rats. We conclude that activation of alpha(2)-adrenoceptors selectively enhances renovascular responses to angiotensin II and vasopressin in SHRs via an enhanced cross talk between the G(i) signal transduction pathway and signal transduction pathways activated by angiotensin II and vasopressin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606648     DOI: 10.1124/jpet.102.047647

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.

Authors:  Edwin K Jackson; Zaichuan Mi; Stevan P Tofovic; Delbert G Gillespie
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Endogenous adenosine contributes to renal sympathetic neurotransmission via postjunctional A1 receptor-mediated coincident signaling.

Authors:  Edwin K Jackson; Dongmei Cheng; Stevan P Tofovic; Zaichuan Mi
Journal:  Am J Physiol Renal Physiol       Date:  2011-11-23

3.  RACK1 regulates angiotensin II-induced contractions of SHR preglomerular vascular smooth muscle cells.

Authors:  Xiao Zhu; Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-18

4.  Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.

Authors:  David S Tofovic; Victor P Bilan; Edwin K Jackson
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

5.  Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.

Authors:  Edwin K Jackson; Zaichuan Mi
Journal:  Hypertension       Date:  2008-04-28       Impact factor: 10.190

6.  Identification and quantification of 2',3'-cAMP release by the kidney.

Authors:  Jin Ren; Zaichuan Mi; Nicolas A Stewart; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2008-11-25       Impact factor: 4.030

7.  Extracellular 2',3'-cAMP is a source of adenosine.

Authors:  Edwin K Jackson; Jin Ren; Zaichuan Mi
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

8.  Influence of alpha2-autoreceptor stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release.

Authors:  Alberto Mota; Serafim Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-26       Impact factor: 3.000

Review 9.  α 2-Adrenoceptors: Challenges and Opportunities-Enlightenment from the Kidney.

Authors:  William A Pettinger; Edwin K Jackson
Journal:  Cardiovasc Ther       Date:  2020-04-29       Impact factor: 3.023

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.